We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Biogen Extends License to Linguamatics for Text Search and Mining
News

Biogen Extends License to Linguamatics for Text Search and Mining

Biogen Extends License to Linguamatics for Text Search and Mining
News

Biogen Extends License to Linguamatics for Text Search and Mining

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Biogen Extends License to Linguamatics for Text Search and Mining"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Linguamatics has announced that Biogen Idec has extended its license to Linguamatics’ I2E text search and mining software.

I2E has been deployed at Biogen Idec since early 2005 and is used by the library and information systems team to solve a diverse range of knowledge discovery problems across the business, in areas such as biomarker discovery, protein-disease associations and toxicology.

The technology is designed to enable the discovery of key information from large collections of text documents that would be impossible or prohibitively time-consuming to find using conventional methods.

The system's linguistic capabilities can be used interactively to extract relevant facts and relationships from unstructured text documents and present them to the user in a structured form.

Commenting on the relationship, Roger Hale, COO of Linguamatics, said, "We are delighted that Biogen Idec have chosen to extend their license."

"This confirms that I2E continues to offer exceptional performance and value across an increasing range of key application areas in the Pharmaceutical and Biotechnology industries."

Advertisement